Transamerica Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Transamerica Financial Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.1K	Buy	2,562 +1,794	+234%	+$29.7K	﹤0.01%	731
2026 Q1	$14.2K	Buy	768 +474	+161%	+$8.32K	﹤0.01%	861
2025 Q4	$4.58K	Buy	294 +220	+297%	+$3.15K	﹤0.01%	978
2025 Q3	$1.11K	Buy	+74	New	+$1.1K	﹤0.01%	1153
2024 Q4	–	Sell	-1	Closed	-$1K	–	587
2024 Q3	$1K	Buy	+1	New	+$14	﹤0.01%	547
2021 Q1	–	Sell	-16	Closed	-$1K	–	209
2020 Q4	$1K	Buy	+16	New	+$281	0.02%	178
2020 Q3	–	Sell	-1	Closed	-$1K	–	453
2020 Q2	$1K	Buy	+1	New	+$18	﹤0.01%	478
2019 Q3	–	Sell	-1	Closed	-$1K	–	472
2019 Q2	$1K	Buy	+1	New	+$18	﹤0.01%	524

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Transamerica Financial Advisors's TAK Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Takeda Pharmaceutical (TAK) stake by 234% in Q2 2026, buying an estimated $29.7K and bringing the position to 2,562 shares worth $41.1K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Transamerica Financial Advisors first reported a position in TAK in Q2 2019 and has held it in 8 quarters since. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Transamerica Financial Advisors held 2,562 shares of Takeda Pharmaceutical worth $41.1K as of Q2 2026.
Transamerica Financial Advisors bought 1,794 Takeda Pharmaceutical shares in Q2 2026, an estimated $29.7K.
Takeda Pharmaceutical made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #731 holding.
Transamerica Financial Advisors first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 8 quarters since.
379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.